Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients
Lu Lu(Fudan University), Kelvin Kai‐Wang To(Hong Kong Science and Technology Parks Corporation), Ivan Fan‐Ngai Hung(Chinese University of Hong Kong), Vincent Chi‐Chung Cheng(Queen Mary Hospital), Bobo Wing-Yee Mok(Chinese University of Hong Kong), Jonathan Daniel Ip(University of Hong Kong), Cyril Chik‐Yan Yip(Queen Mary Hospital), Wan-Mui Chan(University of Hong Kong), Kwok‐Yung Yuen(University of Hong Kong - Shenzhen Hospital), Honglin Chen(University of Hong Kong), Allen Wing‐Ho Chu(University of Hong Kong), Kwok‐Hung Chan(University of Hong Kong), Bosco Hoi‐Shiu Lam, Brian Pui-Chun Chan(University of Hong Kong), Vivien Wai‐Man Chuang(Hospital Authority), Jacky Man‐Chun Chan(University of Hong Kong - Shenzhen Hospital), Ruiqi Zhang(University of Hong Kong), Owen Tak‐Yin Tsang(Hospital Authority), Lin‐Lei Chen(Queen Mary Hospital)
Cited by 131
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Consistent Detection of 2019 Novel Coronavirus in Saliva
|Clinical Infectious Diseases|2020|2k
Coronaviruses — drug discovery and therapeutic options
|Nature Reviews Drug Discovery|2016|1.8k